Neuroprotection in Parkinson's Disease; a Commentary

By Gatto Emilia Mabel   Riobó Natalia   Carreras MarÍa Cecilia   Poderoso Juan José   Micheli Federico E.  

Neurotoxicity Research, Vol. 4, Iss. 2, 2002-01 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's Disease

By Bowers W.J.   Howard D.F.   Federoff H.J.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 58-68

Elsevier

Access to resources Recommend Favorite

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

By Youdim M. B. H.   Fridkin M.   Zheng H.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1455-1471

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

By Li Chao   Guo Yuan   Xie Wenjie   Li Xingang   Janokovic Joseph   Le Weidong  

Neurochemical Research, Vol. 35, Iss. 10, 2010-10 ,pp. : 1546-1556

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotection for Parkinson's disease: a call for clinically driven experimental design

By Bezard E.  

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 393-393

Elsevier

Access to resources Recommend Favorite